Milestone Pharmaceuticals MIST 深 沪
等待开盘 09-20 09:30:00 美东时间
1.55
0.000
0.00%
华盛通- 最 高1.57
- 今 开1.56
- 成交量 23.29万股
- 最 低 1.51
- 昨 收 1.55
- 总市值 5174.33万
- 52周最高 3.52
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.12
- 委 比 30.70%
- 总股本 3338.28万
- 历史最高 27.95
- 量 比 2.02
- 振 幅 3.87%
- 历史最低 1.12
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多快讯 | Milestone Pharmaceuticals Inc：500名患者的3期试验（JX02002）达到了主要终点
Milestone Pharmaceuticals Inc: 500-Patient Phase 3 Trial (JX02002) Met Its Prim...
09-06 19:00
希尔顿集团喜迎在华第700家酒店开业里程碑
重庆康莱德酒店闪耀启幕 上海2024年8月16日 /美通社/ -- 今日，希尔顿集团宣布其大中华区第700家酒店——重庆康莱德酒店正式开业，为集团迎来在华发展又...
08-16 14:21
Milestone Pharmaceuticals GAAP EPS of -$0.14
Milestone Pharmaceuticals press release (NASDAQ:MIST): Q2 GAAP EPS of -$0.14. As of June 30, 2024, Milestone had cash, cash equivalents, and short-term investments of $83.3 million, compared to $66.0 ...
08-09 18:17
Milestone Pharmaceuticals’ Promising Drug Advancements
Milestone Pharmaceuticals (MIST) has released an update. Milestone Pharmaceutic...
08-09 06:18
Milestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
Milestone Pharmaceuticals (MIST) has released an update. Milestone Pharmaceutic...
08-09 06:18
Milestone Pharmaceuticals Q2 2024 Adj EPS $(0.14) Beats $(0.19) Estimate
Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 26.32 percent.
08-09 05:45
快讯 | 迈尔斯通制药公司：截至2024年6月30日的现金余额为8330万美元，预计可以支持运营至2026年。
Milestone Pharmaceuticals Inc: Cash of $83.3 Mln as of June 30, 2024 Expected t...
08-09 04:19
快讯 | milestone pharmaceuticals 第二季度基本每股收益 美元指数 -0.14
Milestone Pharmaceuticals Q2 Basic EPS USD -0.14
08-09 04:18
快讯 | Milestone Pharmaceuticals报告2024年第二季度财务业绩并提供监管和企业更新
Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Pro...
08-09 04:18
快讯 | milestone pharmaceuticals第二季度营业收入 美元指数-966.2万
Milestone Pharmaceuticals Q2 Income From Operations USD -9.662 Million
08-09 04:18
